Dissemin is shutting down on January 1st, 2025

Published in

International Union of Crystallography, Acta Crystallographica Section A: Foundations and Advances, a1(76), p. a209-a209, 2020

DOI: 10.1107/s0108767320097937

American Association for the Advancement of Science, Science, 6510(369), p. 1501-1505, 2020

DOI: 10.1126/science.abd0826

Links

Tools

Export citation

Search in Google Scholar

Structure-based design of prefusion-stabilized SARS-CoV-2 spikes

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Green circle
Published version: archiving allowed
Data provided by SHERPA/RoMEO

Abstract

Stabilizing the prefusion SARS-CoV-2 spike The development of therapeutic antibodies and vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is focused on the spike (S) protein that decorates the viral surface. A version of the spike ectodomain that includes two proline substitutions (S-2P) and stabilizes the prefusion conformation has been used to determine high-resolution structures. However, even S-2P is unstable and difficult to produce in mammalian cells. Hsieh et al. characterized many individual and combined structure-guided substitutions and identified a variant, named HexaPro, that retains the prefusion conformation but shows higher expression than S-2P and can also withstand heating and freezing. This version of the protein is likely to be useful in the development of vaccines and diagnostics. Science , this issue p. 1501